bf/AMEX:XTNT_icon.jpeg

COM:XTANTMEDICAL

Xtant Medical

  • Stock

Last Close

0.53

08/11 21:00

Market Cap

72.89M

Beta: -

Volume Today

49.94K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
11.95M
-
10.16M
14.99%
16.12M
58.74%
24.48M
51.82%
24.25M
0.93%
19.76M
18.49%
16.70M
15.50%
18.75M
12.30%
19.68M
4.92%
17.61M
10.48%
27.09M
53.76%
average payables
3.38M
-
3.32M
1.79%
6.63M
99.62%
9.93M
49.73%
9.89M
0.36%
7.89M
20.25%
4.33M
45.17%
2.24M
48.26%
2.45M
9.54%
3.05M
24.49%
5.27M
72.71%
average receivables
5.97M
-
4.61M
22.82%
9.91M
114.86%
17.19M
73.51%
15.85M
7.77%
11.35M
28.39%
10.06M
11.41%
8.50M
15.46%
7.02M
17.47%
9.00M
28.31%
15.79M
75.40%
book value per share
-8.82
-
-14.25
61.53%
10.70
175.07%
-6.65
162.12%
-38.65
481.52%
-3.70
90.42%
-3.33
9.93%
0.51
115.28%
0.36
29.04%
0.36
0.50%
capex per share
-1.59
-
-0.55
65.46%
-2.73
396.04%
-5.48
100.93%
-1.08
80.29%
-0.05
95.12%
-0.07
25.63%
-0.05
18.22%
-0.02
54.35%
-0.02
24.25%
capex to depreciation
-0.92
-
-0.31
65.76%
-0.46
46.94%
-0.81
74.01%
-0.20
75.77%
-0.09
51.47%
-0.28
195.36%
-0.74
165.72%
-1.59
113.66%
-1.37
14.01%
-0.46
66.40%
capex to operating cash flow
0.12
-
0.04
66.79%
0.25
507.18%
0.40
62.79%
3.02
646.09%
-0.51
117.05%
2.13
513.39%
2.11
0.69%
-4.82
327.95%
0.33
106.86%
0.15
53.67%
capex to revenue
-0.02
-
-0.01
59.50%
-0.04
349.14%
-0.06
69.95%
-0.02
69.35%
-0.01
56.48%
-0.01
57.24%
-0.03
113.15%
-0.04
32.12%
-0.03
20.49%
-0.01
62.37%
cash per share
7.00
-
8.19
17.08%
7.67
6.29%
2.42
68.44%
1.88
22.38%
0.57
69.44%
0.39
31.28%
0.08
79.20%
0.21
159.89%
0.22
1.06%
days of inventory on hand
276.69
-
267.67
3.26%
408.63
52.66%
345.99
15.33%
249.56
27.87%
219.90
11.88%
265.13
20.57%
412.45
55.57%
287.62
30.27%
244.23
15.08%
187.84
23.09%
days payables outstanding
71.21
-
108.56
52.45%
169.08
55.75%
137.94
18.42%
104.58
24.18%
82.17
21.43%
36.03
56.15%
44.10
22.40%
41.91
4.96%
49.31
17.66%
35.92
27.15%
days sales outstanding
52.91
-
45.73
13.55%
94.63
106.90%
77.02
18.60%
56.18
27.06%
50.50
10.10%
57.13
13.12%
47.08
17.59%
47.25
0.36%
68.34
44.62%
59.52
12.91%
debt to assets
0.58
-
0.75
30.05%
0.79
4.92%
0.91
15.13%
1.31
44.88%
1.69
28.75%
1.82
7.53%
0.45
75.43%
0.31
31.13%
0.28
7.97%
0.25
13.15%
debt to equity
-4.34
-
-2.70
37.79%
12.70
570.36%
-18.48
245.53%
-2.37
87.19%
-1.79
24.17%
-1.78
1.02%
1.28
171.91%
0.55
57.31%
0.50
8.40%
0.44
11.13%
dividend yield
earnings yield
-0.49
-
-0.53
9.05%
-0.08
85.28%
-2.78
3,458.01%
-5.02
81.00%
-3.68
26.71%
-0.39
89.48%
-0.21
46.83%
-0.12
40.73%
-0.14
11.89%
enterprise value
39.76M
-
36.36M
8.55%
134.25M
269.21%
135.19M
0.70%
146.53M
8.39%
90.81M
38.02%
94.52M
4.08%
50.29M
46.79%
46.46M
7.62%
58.87M
26.72%
17.09M
70.98%
enterprise value over ebitda
-5.09
-
-7.71
51.34%
-33.76
338.15%
181.21
636.68%
-27.47
115.16%
-113.37
312.67%
119.80
205.66%
37.87
68.39%
-18.42
148.64%
-10.84
41.17%
-1.68
84.48%
ev to operating cash flow
-7.07
-
-4.96
29.81%
-14.75
197.16%
-9.38
36.40%
-269.76
2,774.82%
74.93
127.78%
-228.86
405.44%
-68.80
69.94%
105.83
253.82%
-11.02
110.42%
-1.80
83.71%
ev to sales
1.20
-
1.03
14.39%
2.26
119.81%
1.50
33.60%
1.77
18.08%
1.26
29.09%
1.46
16.18%
0.94
35.48%
0.84
10.84%
1.02
20.80%
0.13
86.77%
free cash flow per share
-14.50
-
-13.97
3.61%
-13.70
2.00%
-19.02
38.86%
-1.44
92.44%
0.05
103.46%
-0.10
295.97%
-0.08
18.04%
-0.02
75.44%
-0.08
285.05%
free cash flow yield
-0.24
-
-0.38
59.05%
-0.41
6.05%
-2.88
606.94%
-0.21
92.74%
0.03
114.75%
-0.06
297.19%
-0.07
9.64%
-0.04
47.55%
-0.11
226.71%
graham net net
-47.54
-
-42.45
10.70%
-126.47
197.94%
-113.90
9.94%
-92.77
18.55%
-5.69
93.87%
-5.01
11.84%
-0.31
93.88%
0.10
133.45%
0.12
14.13%
graham number
76.06
-
78.59
3.32%
25.12
68.04%
52.33
108.37%
173.23
231.00%
22.22
87.17%
6.82
69.31%
1.68
75.36%
0.75
55.62%
0.86
15.12%
income quality
0.44
-
0.70
57.40%
4.18
500.42%
0.74
82.34%
0.01
98.60%
-0.02
266.83%
0.05
390.56%
0.10
107.19%
-0.09
186.98%
0.63
795.28%
-14.42
2,390.31%
intangibles to total assets
0.02
-
0.02
15.38%
0.57
2,337.35%
0.54
5.94%
0.52
2.59%
0.08
84.46%
0.09
5.92%
0.09
2.45%
0.07
25.36%
0.06
10.60%
0.19
218.61%
interest coverage
-1.94
-
-1.11
42.83%
-1.56
41.11%
-0.62
60.60%
-2.57
318.16%
-5.92
130.16%
-0.41
93.11%
-0.13
69.19%
-3.87
2,982.19%
-3.99
3.07%
3.46
186.60%
interest debt per share
48.98
-
48.86
0.25%
145.20
197.19%
134.37
7.46%
101.17
24.71%
7.50
92.59%
6.36
15.24%
0.86
86.47%
0.21
75.73%
0.20
4.47%
inventory turnover
1.32
-
1.36
3.37%
0.89
34.50%
1.05
18.11%
1.46
38.64%
1.66
13.49%
1.38
17.06%
0.88
35.72%
1.27
43.40%
1.49
17.76%
1.94
30.02%
invested capital
-4.34
-
-2.70
37.79%
12.70
570.36%
-18.48
245.53%
-2.37
87.19%
-1.79
24.17%
-1.78
1.02%
1.28
171.91%
0.55
57.31%
0.50
8.40%
0.44
11.13%
market cap
26.13M
-
19.84M
24.09%
27.88M
40.54%
7.02M
74.80%
10.43M
48.54%
19.04M
82.48%
21.22M
11.43%
34.09M
60.67%
47.86M
40.39%
62.10M
29.76%
net current asset value
-13.55M
-
-16.62M
22.63%
-88.76M
434.13%
-102.19M
15.13%
-124.90M
22.22%
-55.52M
55.55%
-55.11M
0.73%
4.41M
108.01%
20.52M
365.01%
23.26M
13.35%
23.61M
1.49%
net debt to ebitda
-1.75
-
-3.50
100.62%
-26.75
663.86%
171.79
742.14%
-25.52
114.85%
-89.60
251.15%
92.91
203.69%
12.20
86.87%
0.55
95.46%
0.59
7.14%
-1.68
383.21%
net income per share
-29.15
-
-19.26
33.92%
-2.62
86.39%
-18.32
598.89%
-34.51
88.40%
-5.93
82.82%
-0.62
89.54%
-0.25
60.25%
-0.07
72.25%
-0.09
31.88%
operating cash flow per share
-12.91
-
-13.43
4.01%
-10.97
18.31%
-13.54
23.43%
-0.36
97.36%
0.10
128.66%
-0.03
130.39%
-0.03
17.65%
0.01
120.03%
-0.06
1,205.05%
payables turnover
5.13
-
3.36
34.40%
2.16
35.79%
2.65
22.58%
3.49
31.89%
4.44
27.27%
10.13
128.07%
8.28
18.30%
8.71
5.22%
7.40
15.01%
10.16
37.27%
receivables turnover
6.90
-
7.98
15.68%
3.86
51.67%
4.74
22.86%
6.50
37.11%
7.23
11.24%
6.39
11.60%
7.75
21.34%
7.72
0.36%
5.34
30.86%
6.13
14.82%
research and ddevelopement to revenue
0.04
-
0.04
5.06%
0.04
11.68%
0.03
22.02%
0.02
20.22%
0.01
38.87%
0.01
14.51%
0.02
27.81%
0.02
0.26%
0.01
33.43%
return on tangible assets
-0.45
-
-0.38
14.20%
-0.04
90.78%
-0.29
724.66%
-1.04
255.82%
-1.64
57.90%
-0.21
87.32%
-0.19
10.89%
-0.11
38.42%
-0.15
30.86%
-0.04
75.72%
revenue per share
75.94
-
64.76
14.72%
71.53
10.44%
84.57
18.23%
54.39
35.68%
6.11
88.78%
4.88
20.10%
1.87
61.63%
0.65
65.45%
0.62
4.72%
roe
3.30
-
1.35
59.09%
-0.24
118.13%
2.76
1,225.04%
0.89
67.60%
1.60
79.36%
0.19
88.39%
-0.48
360.19%
-0.19
60.89%
-0.25
31.22%
-0.05
78.56%
roic
-0.95
-
-0.71
24.86%
-0.01
98.46%
-0.06
453.73%
-0.60
882.36%
-1.70
185.18%
-0.07
96.17%
-0.02
65.36%
-0.09
319.35%
-0.13
36.23%
-0.36
176.86%
sales general and administrative to revenue
0.33
-
0.26
21.60%
0.22
12.63%
0.18
20.17%
0.19
4.20%
0.18
2.97%
0.28
54.00%
0.25
8.70%
0.26
3.28%
0.27
2.02%
0.20
23.77%
shareholders equity per share
-8.82
-
-14.25
61.53%
10.70
175.07%
-6.65
162.12%
-38.65
481.52%
-3.70
90.42%
-3.33
9.93%
0.51
115.28%
0.36
29.04%
0.36
0.50%
stock based compensation to revenue
0.03
-
0.03
4.37%
0.01
46.74%
0.01
58.79%
0.00
55.88%
0.01
274.89%
0.01
17.16%
0.02
155.26%
0.04
96.68%
0.04
6.34%
0.02
49.32%
tangible asset value
-4.43M
-
-8.43M
90.34%
-72.90M
764.67%
-84.55M
15.99%
-114.06M
34.90%
-47.55M
58.31%
-47.92M
0.79%
10.85M
122.64%
27.28M
151.36%
30.62M
12.26%
33.96M
10.91%
tangible book value per share
-10.17
-
-15.45
51.94%
-87.86
468.54%
-79.44
9.58%
-75.10
5.47%
-4.02
94.65%
-3.61
10.11%
0.38
110.54%
0.32
16.17%
0.33
1.96%
working capital
9.52M
-
10.63M
11.65%
23.95M
125.39%
17.86M
25.40%
13.69M
23.39%
22.63M
65.31%
22.86M
1.02%
5.72M
74.99%
33.25M
481.75%
34.10M
2.55%
41.88M
22.81%

All numbers in (except ratios and percentages)